Patents by Inventor Preeti Lal

Preeti Lal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6645499
    Abstract: The invention provides a human ena/VASP-like protein splice variant (EVL1) and polynucleotides which identify and encode EVL1. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of EVL1.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: November 11, 2003
    Assignee: Incyte Corporation
    Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley
  • Publication number: 20030207430
    Abstract: The invention provides human enzyme molecules (HEM) and polynucleotides which identify and encode HEM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of HEM.
    Type: Application
    Filed: August 28, 2002
    Publication date: November 6, 2003
    Inventors: Y. Tom Tang, Dyung Aina M. Lu, Olga Bandman, Henry Yue, Yalda Azimzai, Neil Burford, Preeti Lal, Mariah R. Baughn
  • Publication number: 20030208040
    Abstract: The invention provides human G-protein associated molecules (GPAM) and polynucleotides which identify and encode GPAM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GPAM.
    Type: Application
    Filed: September 23, 2002
    Publication date: November 6, 2003
    Inventors: Preeti Lal, Henry Yue, Dyung Aina M. Lu
  • Publication number: 20030175787
    Abstract: The invention provides mammalian cDNAs which encode mammalian vesicle membrane proteins. It also provides for the use of the cDNAs, fragments, complements, and variants thereof and of the encoded proteins, portions thereof and antibodies thereto for diagnosis and treatment of cell proliferative disorders, particularly cancers of the colon, breast, ovary, uterus, prostate, adrenal gland, and thyroid, and thyroid follicular adenoma and thyroid lymphocytic thyroiditis. The invention additionally provides expression vectors and host cells for the production of the proteins and transgenic model systems.
    Type: Application
    Filed: March 19, 2003
    Publication date: September 18, 2003
    Applicant: Incyte Corporation
    Inventors: Jennifer L. Hillman, Henry Yue, Preeti Lal, Matthew R. Kaser
  • Publication number: 20030170219
    Abstract: The invention provides human disease associated protein kinases and polynucleotides (collectively designated DAPK) which identify and encode them. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention further provides methods for diagnosing and treating disorders associated with expression of human disease associated protein kinases.
    Type: Application
    Filed: January 24, 2001
    Publication date: September 11, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Olga Bandman, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Preeti Lal, Surya K. Goli, Purvi Shah
  • Publication number: 20030171275
    Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
    Type: Application
    Filed: June 21, 2002
    Publication date: September 11, 2003
    Inventors: Mariah R. Baughn, Neil Burford, Janice Au-Young, Dyung Aina M. Lu, Junming Yang, Roopa Reddy, Preeti Lal, Jennifer L. Hillman, Yalda Azimzai, Henry Yue, Danniel B. Nguyen, Monique G. Yao, Ameena R. Gandhi, Y. Tom Tang, Farrah A. Khan
  • Publication number: 20030166043
    Abstract: The present invention provides a novel human tubby homolog (NHT) and polynucleotides which identify and encode NHT. The invention also provides expression vectors, host cells, agonists, antibodies, or antagonists. The invention also provides methods for treating disorders associated with appetite and eating.
    Type: Application
    Filed: February 12, 2001
    Publication date: September 4, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Samuel T. Labrie, Preeti Lal, Lynn E. Murry
  • Publication number: 20030166199
    Abstract: The invention provides a human serine dehydratase homolog (SDHH) and polynucleotides which identify and encode SDHH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of SDHH.
    Type: Application
    Filed: August 8, 2001
    Publication date: September 4, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Neil C. Corley, Karl J. Guegler, Chandra Patterson
  • Patent number: 6610526
    Abstract: The invention provides a human E1-like protein (HELPR) and polynucleotides which identify and encode HELPR. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HELPR.
    Type: Grant
    Filed: March 13, 1998
    Date of Patent: August 26, 2003
    Assignee: Inctye Corporation
    Inventors: Preeti Lal, Neil C. Corley, Henry Yue
  • Publication number: 20030152949
    Abstract: The invention provides human phosphatases (PP) and polynucleotides which identify and encode PP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PP.
    Type: Application
    Filed: July 19, 2002
    Publication date: August 14, 2003
    Inventors: Olga Bandman, Y. Tom Tang, Yalda Azimzai, Henry Yue, Mariah R. Baughn, Jennifer L. Hillman, Preeti Lal, Eureka Wang, Ameena R. Gandhi, Jennifer L. Policky, Preete Mathur
  • Publication number: 20030148363
    Abstract: The invention provides human hydrolase-like molecules (HHLM) and polynucleotides which identify and encode HHLM. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HHLM.
    Type: Application
    Filed: February 5, 2003
    Publication date: August 7, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Olga Bandman, Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Karl J. Guegler, Purvi Shah
  • Publication number: 20030148934
    Abstract: The invention provides human growth factor modulators (GFMO) and polynucleotides which identify and encode GFMO. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GFMO.
    Type: Application
    Filed: June 30, 1998
    Publication date: August 7, 2003
    Inventors: NEIL C. CORLEY, GINA A. GORGONE, HENRY YUE, PREETI LAL, MARIAH R. BAUGHN
  • Publication number: 20030143691
    Abstract: The invention provides a human testin (HTES) and polynucleotides which identify and encode HTES. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HTES.
    Type: Application
    Filed: February 3, 2003
    Publication date: July 31, 2003
    Applicant: Incyte Genomics, Inc.
    Inventors: Preeti Lal, Karl J. Guegler, Neil C. Corley
  • Publication number: 20030138895
    Abstract: The invention provides human drug metabolizing enzymes (DME) and polynucleotides which identify and encode DME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of DME.
    Type: Application
    Filed: July 31, 2002
    Publication date: July 24, 2003
    Inventors: Y. Tom Tang, Mariah R. Baughn, Monique G. Yao, Olga Bandman, Yalda Azimzai, Preeti Lal, Ameena R. Gandhi, Huijun Z. Ring, Leo L. Shih, Junming Yang, Jennifer L. Policky, Henry Yue
  • Publication number: 20030129612
    Abstract: The invention provides human DNA modification proteins (DNAMP) and polynucleotides which identify and encode DNAMP. The invention also provides expression vectors, host cells, antibodies, agonists, and antogonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of DNAMP.
    Type: Application
    Filed: July 11, 2002
    Publication date: July 10, 2003
    Inventors: Y. Tom Tang, Preeti Lal, Jennifer L. Hillman, Henry Yue, Yalda Azimzai, Dyung Aina M. Lu, Mariah R. Baughn
  • Publication number: 20030124706
    Abstract: The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.
    Type: Application
    Filed: June 21, 2002
    Publication date: July 3, 2003
    Inventors: Junming Yang, Mariah R. Baughn, Neil Burford, Janice Au-Young, Dyung Aina M. Lu, Roopa Reddy, Henry Yue, Daniel B. Nguyen, Y. Tom Tang, Monique G. Yao, Preeti Lal
  • Publication number: 20030124106
    Abstract: The invention provides human oxidoreductase proteins (ORP) and polynucleotides which identify and encode ORP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with expression of ORP.
    Type: Application
    Filed: June 13, 2002
    Publication date: July 3, 2003
    Inventors: Henry Yue, Preeti Lal, Y. Tom Tang, Jennifer L. Hillman, Mariah R. Baughn, Yalda Azimzai, Dyung Aina M. Lu
  • Publication number: 20030119111
    Abstract: The invention provides human G-protein coupled receptors (GCREC) and polynucleotides which identify and encode GCREC. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of GCREC.
    Type: Application
    Filed: August 28, 2002
    Publication date: June 26, 2003
    Inventors: Preeti Lal, Y TOm Tang, Chandra Arvizu, Monique G Yao, Leo L Shih, Catherine M Tribouley, Dyung Aina M Lu, Henry Yue, Farrah A Khan, Jennifer L Policky, Janice Au-Young, Junming Yang, Lee Hardland, Roderick T Walsh, Terence P Lo, Mark L Borowsky
  • Publication number: 20030119730
    Abstract: The invention provides two human phospholipid binding proteins (PLBP) and polynucleotides which identify and encode PLBP. The invention also provides expression vectors, host cells, agonists, antibodies and antagonists. The invention also provides methods for treating and preventing disorders associated with expression of PLBP.
    Type: Application
    Filed: June 11, 2001
    Publication date: June 26, 2003
    Applicant: Incyte Pharmaceuticals, Inc.
    Inventors: Preeti Lal, Jennifer L. Hillman, Neil C. Corley, Purvi Shah
  • Publication number: 20030113846
    Abstract: The invention provides human lipid metabolism enzymes (LME) and polynucleotides which identify and encode LME. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of LME.
    Type: Application
    Filed: August 28, 2002
    Publication date: June 19, 2003
    Inventors: Preeti Lal, Monique G. Yao, Henry Yue, Ameena R. Gandhi, Farrah A. Khan, Y. Tom Tang, Danniel B. Nguyen, Jennifer L. Policky, Debopriya Das, Jennifer L. Hillman, Narinder K. Walia, April Hafalia, Catherine M. Tribouley